Cardiovascular Disease — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for cardiovascular disease. 41 active patents protecting 1 drugs from 1+ originators. First major cliff: 2028. Daily refresh.

1
Approved drugs
41
Active US patents
72/100
Avg vulnerability
—
Annual revenue covered

Originators in Cardiovascular Disease

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Scilex Pharms 41 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating cardiovascular disease. Each bar = one year. Y-axis scaled to peak year (17 patents).

11
28
6
29
17
33
1
34
5
36
1
37

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Colcrys
COLCHICINE
 Scilex Pharms 41 72 — 2028-10-06

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
8415395 Colcrys method of use 80 2028-10-06
8093297 Colcrys method of use 80 2028-10-06
8093296 Colcrys method of use 80 2028-10-06
8093298 Colcrys method of use 80 2028-10-06
7964648 Colcrys method of use 80 2028-10-06
7981938 Colcrys method of use 80 2028-10-06
7964647 Colcrys method of use 80 2028-10-06
8097655 Colcrys method of use 80 2028-10-06
8415396 Colcrys method of use 80 2028-10-06
7619004 Colcrys method of use 80 2028-12-03

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
10226423 Colcrys formulation 42 2037-12-20
9907751 Colcrys formulation 42 2036-11-22
10383821 Colcrys formulation 42 2036-11-22
10383820 Colcrys method of use 62 2036-11-22
9399036 Colcrys method of use 62 2033-08-22
9675613 Colcrys method of use 62 2033-08-22
9789108 Colcrys method of use 62 2033-08-22
8927607 Colcrys method of use 62 2033-08-22
9555029 Colcrys method of use 62 2033-08-22
10130585 Colcrys method of use 70 2034-05-09

Related